News

Article

Cytiva Completes Renovation on Fast Trak cGMP Facility

The updated facility is 60,000 square feet and is equipped with bioprocessing capabilities ranging from 10L to 2000L.

Cytiva announced on June 24, 2020 that it has completed a renovation of its Fast Trak cGMP contract biomanufacturing and process development site in Marlborough, MA.

The updated facility is 60,000 square feet and is equipped with bioprocessing capabilities ranging from 10L to 2000, according to a company press release. The site offers technical support and single-use biomanufacturing expertise to biotechnology companies looking for assistance in bringing therapeutics to market.

“Biotechnology companies are increasingly outsourcing their manufacturing, whether to access expertise, capacity, or both,” said Olivier Loeillot, senior vice-president, BioProcess at Cytiva, in the press release. “Our upgraded Fast Trak cGMP facility will provide our customers, particularly the small to mid-size companies, with the services and expertise needed to help expedite their processes and get to market faster.”

Source: Cytiva

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content